Clinical Handbook of Psychotropic Drugs

Ric M. Procyshyn, BSc (Pharm), MSc, PharmD, PhD is affiliated with the British Columbia Mental Health & Addictions Research Institute and Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.Kalyna Z. Bezchlibnyk-Butler, BScPhm, FCSHP is now in private practice.J. Joel Jeffries, MB, FRCPC is affiliated with the Centre for Addiction andMental Health and Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Table of Contents (preliminary):AntidepressantsSelective Serotonin Reuptake Inhibitors (SSRI) * Norepinephrine Dopamine Reuptake Inhibitor (NDRI) * Serotonin NorepinephrineReuptake Inhibitor (SNRI) * Serotonin-2 Antagonists/Reuptake Inhibitors (SARI) * Serotonin-1A Agonist/Serotonin Reuptake Inhibitor* Serotonin Stimulator / Serotonin Modulator * Noradrenergic/Specific Serotonergic Antidepressants (NaSSA) * Nonselective CyclicAntidepressants * Monoamine Oxidase Inhibitors * Reversible Inhibitor of MAO-A (RIMA) * Irreversible Monoamine Oxidase (A&B)Inhibitors (MAOIs) * Irreversible MAO-B Inhibitor * Effects of Antidepressants on Neurotransmitters/Receptors * Pharmacological Effectsof Antidepressants on Neurotransmitters/Receptors * Frequency of Adverse Reactions to Antidepressants at Therapeutic Doses *Antidepressant Doses and Pharmacokinetics * Switching Antidepressants * Antidepressant Augmentation StrategiesElectroconvulsive Therapy (ECT)Bright Light Therapy (BLT)Repetitive Transcranial Magnetic Stimulation (rTMS)Antipsychotics"Second-Generation" Antipsychotics/SGAs * "Third-Generation" Antipsychotic/TGA * "First-Generation" Antipsychotics/FGAs * Effectsof Antipsychotics on Neurotransmitters/Receptors * Pharmacological Effects of Antipsychotics on Neurotransmitters/ReceptorSubtypes * Relative Tolerability Profiles of Antipsychotics * Frequency of Adverse Reactions to Antipsychotics at Therapeutic Doses *Antipsychotic Doses and Pharmacokinetics (Oral and Short-Acting Injections) * Comparison of Long-Acting IM Antipsychotics * SwitchingAntipsychotics * Antipsychotic Augmentation StrategiesAntipsychotic-Induced Extrapyramidal Side Effects and Their ManagementExtrapyramidal Adverse Effects of Antipsychotics * Treatment Options for Extrapyramidal Side Effects * Effects on ExtrapyramidalSymptoms * Comparison of Agents for Treating Acute Extrapyramidal Side Effects * Doses and Pharmacokinetics of Agents for TreatingAcute Extrapyramidal Side EffectsAnxiolytic (Antianxiety) AgentsBenzodiazepines * Comparison of the Benzodiazepines * BuspironeHypnotics/SedativesL-Tryptophan * Comparison of Hypnotics/SedativesMood StabilizersLithium * Anticonvulsants * Comparison of Anticonvulsants * Frequency of Adverse Reactions to Mood Stabilizers at Therapeutic DosesDrugs for ADHDPsychostimulants * Atomoxetine * Comparison of Drugs for ADHD * alpha2 Agonists * Augmentation Strategies in ADHDDrugs for Treatment of DementiaCholinesterase Inhibitors * Memantine * Comparison of Drugs for Treatment of DementiaSex-Drive DepressantsComparison of Sex-Drive DepressantsDrugs of AbuseAlcohol * Stimulants * Hallucinogens * Opioids * Inhalants/Aerosols * Gamma-hydroxybutyrate (GHB)/Sodium Oxybate * Flunitrazepam(Rohypnol) * Nicotine/TobaccoTreatment of Substance Use DisordersAcamprosate * Disulfiram * Naltrexone * Buprenorphine * Methadone * Pharmacotherapy for Nicotine/Tobacco Use DependenceUnapproved Treatments of Psychiatric DisordersAdrenergic Agents * Dopaminergic Agents * GABA Agents/Anticonvulsants * Hormones * NMDA Agents * MiscellaneousNatural Health ProductsPharmacogenomic Information for Common Psychiatric DrugsGlossaryResources for Information on Drug Use in Pregnancy and Effectson Breast MilkNeuroscience-Based NomenclaturePatient Information SheetsIndex of Drugs